S

Sumitomo Chemical Co Ltd
XMUN:SMM

Watchlist Manager
Sumitomo Chemical Co Ltd
XMUN:SMM
Watchlist
Price: 3.178 EUR -0.25% Market Closed
Market Cap: €9.8B

Sumitomo Chemical Co Ltd
Investor Relations

Sumitomo Chemical is a Japanese chemical manufacturer that makes the raw materials and specialty ingredients used by other companies. Its businesses include basic chemicals and plastics, materials for electronics such as displays and semiconductors, crop protection products for farmers, and products tied to health and environmental uses. In simple terms, it sells the building blocks that go into things like electronics, farm inputs, industrial goods, and some healthcare-related products. Most of its customers are other businesses, not consumers. Electronics makers buy its high-performance materials, industrial customers buy its chemical intermediates and plastics, and agricultural distributors and farmers buy its crop protection products. The company makes money by manufacturing these products and selling them through long-term supply relationships, often under contracts or through established distribution channels. What makes Sumitomo Chemical different is that it sits high up in the value chain, where chemistry and material science matter more than branding. Its products are often designed to meet very specific technical needs, so customers care about reliability, purity, and performance. That gives the company a role as an upstream supplier to industries that need specialized chemicals rather than a simple commodity producer.

Show more
Loading...
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2026
Call Date
Feb 3, 2026
AI Summary
Q3 2026

Profit Growth: Core operating income and net income attributable to owners of the parent both saw significant year-on-year increases, with Q3 net income exceeding previous forecasts.

Segment Performance: Profits were boosted by strong performances at Sumitomo Pharma, gains from divestitures, and structural reforms, despite sales revenue declining in most segments.

Guidance Raised: Full-year guidance for core operating income was raised by JPY 15 billion to JPY 200 billion, and net income guidance increased by JPY 1.5 billion to JPY 55 billion.

Dividend Hike: The year-end dividend was increased to JPY 7.5 per share, raising the annual dividend to JPY 13.5 with an expected payout ratio of about 40%.

Inventory Adjustments: Inventory levels are improving in major regions except South America, which still faces challenges.

Semiconductor Demand: Demand for semiconductor materials is recovering faster than expected, supporting improved outlooks in ICT & Mobility Solutions.

Key Financials
Sales Revenue
JPY 1.7063 trillion
Core Operating Income
JPY 186.8 billion
Operating Income
JPY 180.4 billion
Net Income Attributable to Owners of the Parent
JPY 87.4 billion (Q3), JPY 55 billion (full-year forecast)
Free Cash Flow
JPY 71.8 billion
Interest-Bearing Debt
JPY 1.2215 trillion
D/E Ratio
0.96x
Dividend Per Share
JPY 7.5 (year-end), JPY 13.5 (annual)
Payout Ratio
approx. 40%
Exchange Rate (USD/JPY)
JPY 148.71 to a dollar (average for term)
Naphtha Price
JPY 65,000 per kiloliter (average for term)
Earnings Call Recording
Other Earnings Calls

Management

Mr. Keiichi Iwata
President & Representative Director
No Bio Available
Keigo Sasaki
Managing Executive Officer of Accounting, Finance & Corporate Communications Dept.
No Bio Available
Mr. Hiroshi Niinuma
Executive VP & Director
No Bio Available
Mr. Noriaki Takeshita
Senior Managing Executive Officer & Director
No Bio Available
Mr. Seiji Takeuchi
Senior Managing Executive Officer
No Bio Available
Mr. Kenji Ohno
Managing Executive Officer
No Bio Available

Contacts

Address
TOKYO-TO
Chuo-Ku
7F, Tokyo Nihombashi Tower, 2-7-1, Nihombashi
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett